ID3 Prescribing Patterns for Treatment of Upper Respiratory Infections

OBJECTIVE: This purpose of this study was to estimate the value of HIV prevention using the contingent valuation methodology.
METHODS: Two convenience samples of 452 high-risk individuals (homosexual) and 155 low-risk individuals (heterosexual) were collected from selected sites across the state of Missouri. Subjects completed a 60 item questionnaire on their knowledge, attitudes, beliefs, and sexual behaviors. A series of willingness to pay (WTP) questions were asked to estimate the value of 98% protection (i.e., condom use) and 100% protection (i.e., abstinence) from HIV infection. Additionally, two willingness to be paid (WTBP) questions were asked to estimate the cost of behavior change.
RESULTS: The results of the study showed high-risk individuals placed a greater value on the benefits of HIV prevention than did individuals at low-risk of HIV infection. The benefits of condom use against infection from HIV were valued at $261/month for subjects in the high-risk sample and $238/month for individuals in the low-risk sample. The average monetary benefits of abstinence against HIV infection were estimated at $305/month for high-risk individuals, compared to $249/month among individuals in the low-risk sample. Utility for each preventive behavior (condom use and abstinence) was calculated using a cost-to-benefit ratio (WTBP/WTP). Utilities were regressed on demographic and risk variables. a high-risk individual's utility for 98% protection was associated with greater exposure risk to HIV and knowledge of an AIDS-related death. The low-risk sample was not statistically significant, and no statistical relationships were found between independent variables.
CONCLUSIONS: While subject to methodological limitations, the results from this research provide estimates of the value of HIV prevention strategies. Further research in the area of WTP and HIV prevention is advocated.     

Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome

A patient with Wiskott-Aldrich syndrome who developed Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis (EBV-HLH) is described in this study. At 4 mo of age the patient developed fever associated with bicytopenia and splenomegaly. Analysis of a bone marrow specimen revealed extensive haemophagocytosis, and in situ hybridization for EBV of the bone marrow specimen using an EBV-encoded RNA probe was positive. Diagnosis of EBV-HLH was established and immunotherapy with HLH-94 protocol was started. HLH has been described in patients with other well-defined primary immunodeficiencies such as X-linked lymphoproliferative syndrome, Chediak-Higashi syndrome and Griscelli disease. Also, HLH was reported recently in severe combined immunodeficiency and DiGeorge syndrome.

Conclusion: The possibility of an underlying primary immunodeficiency should be considered in paediatric patients who present with HLH during infancy.     

Male Andropause : A Myth or Reality

Male andropause, male climacteric or viropause is a condition in which men suffer from complex symptomatology due to low androgen level with aging. After the age of 40 years testosterone level starts declining and andropause corresponds to the age at which a pathogenic threshold is reached. This review summarizes the etiology, consequences, screening, diagnosis, monitoring of androgen deficiency in aging male (ADAM). The pros and cons of testosterone replacement therapy (TRT) in elderly male have been discussed. Currently oral, transdermal, transbuccal, intramuscular, and subcutaneous implants are available for clinical use. The choice is made by physicians based on therapeutic indication and patient preferences.Key Words: Andropause, Aging male, Testosterone replacement therapy     

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients

The morbidity and lethality of AL amyloidosis is caused by the deposition of lg light chains as fibrillar amyloid protein in vital organs, disrupting their function, and not by the generally low burden of clonal plasma cells that produce the paraproteins. Survival of patients with AL amyloidosis is no more than 1 to 2 years from the time of diagnosis with current management approaches. Clearly, more effective therapies are needed for this rapidly lethal disease. Five patients were treated with dose-intensive melphalan and blood stem cell support and followed for a period of 1 year. Patients were diagnosed with AL amyloidosis by tissue biopsy and categorized by performance status and organ involvement. Their plasma cell dyscrasias were evaluated with immunofixation electrophoresis of serum and urine specimens, quantitative serum lgs, and immunohistochemical staining of bone marrow biopsy specimens. After treatment with dose-intensive intravenous melphalan followed by infusion of autologous growth-factor- mobilized blood stem cells, clinical evaluations and plasma cell studies were repeated at 3 and 12 months. Three men and 2 women aged 38 to 53 years were treated. Median performance status (SWOG) was 2 (1 to 3), and clinical presentations included nephrotic syndrome (n = 1), symptomatic cardiomyopathy (n = 1), gastrointestinal involvement with polyneuropathy (n = 2), and hepatomegaly (n = 1). With a median follow- up of 13 months (12 to 17 months), all five patients are well and have shown stable or improved performance status and clinical remission of organ-related dysfunction, including a 50% reduction in daily proteinuria with no change in creatinine, reversal of symptoms of cardiomyopathy and reductions of posterior wall and septal thickening, reversal of polyneuropathy and gastric atony, and resolution of hepatomegaly by computed tomographic scan. In 3 of the 5 patients (60%) at 12 months after treatment, plasma cell dyscrasias could not be detected. Dose-intensive chemotherapy with intravenous melphalan and growth-factor-mobilized blood stem cell support is feasible therapy for patients with AL amyloidosis, even when there is clinical evidence of cardiac involvement. At least some patients with AL amyloidosis achieve complete remission of their plasma cell dyscrasia, improvement in performance status, and clinical remission of organ-specific disease after this form of treatment.     

Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib

The Bernard-Soulier syndrome is an inherited bleeding disorder that is due to a deficiency in platelet glycoprotein Ib. Bernard-Soulier platelets fail to agglutinate in response to ristocetin despite normal levels of factor VIII:von Willebrand factor. We report a patient who developed severe refractory thrombocytopenia postsurgically while receiving procainamide therapy. Thrombocytopenia was immune mediated since the patient's platelets bore high levels of antiplatelet antibody. Radioimmunoprecipitation studies demonstrated that the autoantibodies had specificity for platelet glycoproteins Ib and V as well as platelet HLA. The patient's plasma as well as purified immunoglobulin G completely inhibited the ristocetin-induced aggregation of normal platelets but did not inhibit adenosine diphosphate-induced aggregation. The laboratory studies revealed that this patient suffered from antibody-mediated thrombocytopenia with unusual characteristics that we have called pseudo-Bernard-Soulier syndrome.     

Patterns of emergence of the human mental nerve

This study investigated the path of emergence of the mental nerve in a number of human population groups. Skeletal material comprised 117 Negro skulls (53 males), 114 caucasoid skulls (62 males) and 100 pre-contact Maori skulls (70 males). In each case, the path of emergence was classified into posterior, anterior, right-angled or multiple. Those cases with severely resorbed alveolar ridges that made classification difficult were excluded from the study. Additionally, 56 cadaveric mandibles were examined, in which an osteotomy of 1cm was made on either side of the mental foramen to expose the nerve. The most common pattern of emergence in caucasoids and Maoris was a posterior direction (86.7% of caucasoid males, 90.2% of caucasoid females; 85.5% of Maori males, 93.1% of Maori females). In Negroes the most common pattern was a right-angled path of emergence (45.8% of males, 45.0% of females), with this difference between population groups being statistically significant (Pearson's chi(2): males=23.4, females=45-97; P<0.01). Multiple foramina were rare, with the highest incidence being in Maori and Negro males. Cadaveric data supported the findings of the skeletal investigation, with the dominant emergence recorded as posteriorly directed (80.7% of males, 86.6% of females). It was concluded that while the traditionally accepted ontogenetic explanation for the inclination of the mental nerve might be applicable to caucasoids and Maoris, it fails to explain the observed right-angled emergence pattern in Negroes. Hence, the nerve's emergence might be genetically, rather than functionally, determined. The study did not show a measurable anterior loop in the emergence of the mental nerve that would have any significant impact on treatment planning for implants in the anterior mandible.